Keyphrases
Heart Failure Patients
100%
MicroRNA
100%
Preserved Ejection Fraction
100%
Comorbidity
25%
Pathophysiological Mechanisms
16%
Cardiomyocytes
16%
Pathophysiology
8%
Gene Expression
8%
Low-grade Inflammation
8%
Molecular Mechanism
8%
Potential Biomarkers
8%
Gene Regulatory Network
8%
Cardiac Function
8%
Personalized Therapy
8%
Diastolic Dysfunction
8%
Non-coding RNA (ncRNA)
8%
One-size-fits-all
8%
Microvascular Dysfunction
8%
Therapy Approaches
8%
Gene Regulation
8%
Circulating microRNA
8%
Contractile Element
8%
Nitric Oxide Bioavailability
8%
Obesity-related Hypertension
8%
Obesity Diabetes
8%
Complexity Level
8%
Complex Syndrome
8%
Medicine and Dentistry
microRNA
100%
Ejection Fraction
100%
Congestive Heart Failure
100%
Cardiac Muscle Cell
16%
Comorbidity
16%
Nitric Oxide
8%
Diastolic Dysfunction
8%
Biological Marker
8%
Pathophysiology
8%
Diabetes
8%
Gene Expression
8%
Heart Function
8%
Gene Control
8%
Bioavailability
8%
Personalized Medicine
8%
Multiple Chronic Conditions
8%
Untranslated RNA
8%
Circulating microRNA
8%
INIS
patients
100%
heart failure
100%
therapy
23%
populations
15%
levels
7%
hypertension
7%
size
7%
morbidity
7%
reviews
7%
biological markers
7%
rna
7%
genes
7%
inflammation
7%
obesity
7%
nitric oxide
7%
biological availability
7%
gene regulation
7%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA
100%
Congestive Heart Failure
100%
Comorbidity
16%
Inflammation
8%
Nitric Oxide
8%
Diastolic Dysfunction
8%
Pathophysiology
8%
Syndrome
8%
Biological Marker
8%
Bioavailability
8%
Multiple Chronic Conditions
8%
Circulating microRNA
8%
Untranslated RNA
8%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Heart Ejection Fraction
100%
Cardiac Muscle Cell
16%
Comorbidity
16%
Nitric Oxide
8%
Gene Expression
8%
Regulatory Network
8%
Heart Function
8%
Gene Control
8%
Non-Coding RNA
8%
Engineering
Dysfunction
100%
Cardiomyocytes
100%
Individual Patient
50%